Nucleus Software Board Approves RSU Scheme 2026 and Terminates ESOP Scheme 2015
Nucleus Software board meeting on March 25, 2026, approved termination of ESOP Scheme 2015 and introduction of RSU Scheme 2026 with 10,00,000 RSUs pool. The new scheme will be implemented through Nucleus Software Equity Incentive Trust, primarily using secondary market acquisitions. RSUs have 1-4 year vesting periods and 2-year exercise windows, with pricing linked to market rates and potential committee discounts.

*this image is generated using AI for illustrative purposes only.
Nucleus Software Exports Limited announced major changes to its employee compensation structure following a board meeting held on March 25, 2026. The meeting, which commenced at 09:30 am and concluded at 05:55 pm, resulted in the termination of the existing employee stock option plan and approval of a new restricted stock unit scheme.
Board Decisions and Scheme Termination
The board approved the termination of ESOP Scheme 2015 and dissolution of the Nucleus Software Employee Welfare Trust. This decision marks a significant shift in the company's employee incentive strategy, moving from traditional stock options to restricted stock units.
New RSU Scheme 2026 Details
The newly approved Nucleus Software RSU Scheme 2026 introduces several key features designed to benefit eligible employees:
| Parameter: | Details |
|---|---|
| RSU Pool Size: | 10,00,000 (Ten Lakhs) RSUs |
| Share Face Value: | Rs. 10/- each |
| Administration: | Nomination and Remuneration/Compensation Committee |
| Implementation: | Trust route through Nucleus Software Equity Incentive Trust |
| Primary Acquisition Mode: | Secondary market purchases |
The RSU pool may be adjusted for corporate actions including bonus issues, rights issues, stock splits, consolidations, mergers, demergers, or other capital structure reorganizations.
Trust Formation and Share Acquisition
The board approved the formation of Nucleus Software Equity Incentive Trust, an irrevocable trust that will acquire equity shares either through fresh allotment from the company or secondary market acquisition. The trust will primarily focus on secondary market purchases to fulfill RSU obligations.
Additionally, the board authorized the company to provide loans to the trust for purchasing equity shares and approved the trust's acquisition of equity shares through secondary market transactions.
Scheme Terms and Conditions
The RSU scheme includes comprehensive terms for employee participation:
Vesting and Exercise Framework
| Aspect: | Details |
|---|---|
| Vesting Period: | Minimum 1 year, maximum 4 years from grant date |
| Exercise Window: | Maximum 2 years from vesting date |
| Exercise Price: | Linked to market price with potential committee-approved discounts |
| Minimum Price: | Cannot fall below share face value |
Pricing and Re-pricing Provisions
The exercise price will be determined by the committee at grant time, linked to market price as defined in the scheme. The committee has authority to provide suitable discounts on market price while ensuring the exercise price never falls below the Rs. 10/- face value.
Notably, the committee retains power to re-price grants if they become unattractive due to share price declines, subject to SEBI regulations and shareholder approval.
Subsidiary Employee Inclusion
The board extended the scheme's reach by approving RSU grants to eligible employees of subsidiary companies, both in India and internationally. This expansion demonstrates the company's commitment to aligning global workforce incentives with corporate performance.
Regulatory Compliance
The scheme complies with SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, ensuring adherence to regulatory requirements for employee benefit programs. The disclosure was made under Regulation 30 of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.
Historical Stock Returns for Nucleus Software
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +7.24% | +0.44% | -2.13% | -22.16% | -4.39% | +58.32% |
How will the transition from ESOPs to RSUs impact Nucleus Software's ability to attract and retain talent compared to competitors still offering traditional stock options?
What market conditions or share price movements might trigger the committee to exercise its re-pricing authority for existing RSU grants?
Will the company's focus on secondary market purchases for RSU fulfillment create additional buying pressure that could influence the stock's trading dynamics?


































